Arcus Biosciences (RCUS) is down -9.2%, or -$2.14 to $21.15.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RCUS:
- Mereo Biopharma Stock (MREO) Collapses over 90% after Failed Trials
- These Are the Most and Least Likely Biotech Takeover Targets for 2026
- Arcus Biosciences Amends Loan Facility, Extends Maturity Terms
- Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
- Arcus Biosciences price target lowered to $44 from $56 at Citi